Lung Cancer

Pathologists and laboratory professionals are key members of the multidisciplinary team involved in the diagnosis, testing, and management of patients with lung cancer, including advanced non-small cell lung cancer (NSCLC). While the evolution of targeted therapies has significantly improved outcomes and quality of life in patients with advanced NSCLC, it can be difficult to keep up with recent advances in this field. ASCP is committed to developing education to help you increase your awareness of current and emerging treatment options for patients with advanced NSCLC, develop and apply effective testing algorithms for patients with advanced NSCLC, and guide medical oncologists and other multidisciplinary colleagues on their use to ensure appropriate treatment selection.

Educational Activities
Activities

ASCP Project ECHO® Videoconference Series

This series will delve deeper into the concepts presented in the online tumor board simulation to provide pathologists and laboratory professionals with knowledge related to best practices in advanced NSCLC diagnosis, testing, and management and guidance on real-life challenges they may face.

The videoconference series will be CME/CMLE-accredited, consisting of one-hour, bi-monthly sessions utilizing the Project ECHO® approach. This approach features virtual, synchronous web conferences utilizing a proven model established by the University of New Mexico in 2007 that leverages technology to partner learners with specialty mentors through a continuous learning videoconferencing platform. The ECHO model leverages technology to provide access to scarce resources, help participants master complex topics through case-based learning, facilitate peer-to-peer sharing of best practices to improve knowledge and outcomes, reduce peer isolation, and foster professional development.

Each ECHO session will consist of a 20-minute didactic presentation from a subject matter expert on a topic related to best practices in advanced NSCLC diagnosis, testing, and management. In the remaining 40 minutes, two participants will present and share real-world cases and challenges from their institutions and seek feedback from participants and subject matter experts.

Upcoming Events

Videoconference 1: Optimizing Test Ordering for Patients with Advanced NSCLC

Date: Thursday, April 22, 2021

Time: 1-2 p.m. Central Time

Credit: 1 hour CME/CMLE

Register Today

The first of four bimonthly videoconferences on advanced NSCLC, Optimizing Test Ordering for Patients with Advanced NSCLC will provide pathologists and laboratory professionals with knowledge related to best practices in advanced NSCLC diagnosis, testing, and management and guidance on real-life challenges they may face, including:

  • Key actionable driver mutations
  • Effective, comprehensive testing algorithms
  • Current and emerging therapies and treatment pathways
  • The impact of COVID-19 on the continuity of diagnosis and care
  • The importance of effective communication and a team-based approach

Would you like to present during this ECHO?
ASCP is recruiting 2 individuals to share challenges and/or best practices in optimizing NSCLC test ordering. If you are interested, we want to hear from you! Please contact grants@ascp.org to learn more.

Watch for additional sessions in the series:

Thurs 4/22 1-2 p.m. Central Time  Optimizing Advanced NSCLC Test Ordering

Thurs 6/24 1-2 p.m. Central Time  Best Practices in Advanced NSCLC Specimen Management

Thurs 8/26 1-2 p.m. Central Time  Overcoming Challenges to Molecular Testing in Advanced NSCLC

Thurs 10/7 1-2 p.m. Central Time  Advances in Targeted Therapies for Advanced NSCLC

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.

Advanced Non-Small Cell Lung Cancer Molecular Tumor Board Simulation

This CME/CMLE-accredited 1-hour molecular tumor board simulation is designed to help pathologists, laboratory professionals, and other members of the interdisciplinary cancer care team gain deeper scientific knowledge and skills in diagnosing, testing, and managing advanced non-small cell lung cancer (NSCLC). Throughout the highly interactive molecular tumor board simulation, a multidisciplinary faculty panel will discuss multiple patient cases involving advanced NSCLC, and you will answer questions designed to help you carefully consider the nuances of each case, building your knowledge and skills related to the detection and optimal management of advanced NSCLC.

Register

The activity offers 1.0 CME/CMLE credit.

Register Review Case 1 (YouTube) Review Case 2 (YouTube)

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.

Advanced Non-Small Cell Lung Cancer Twitter Chat

ASCP hosted a CME/CMLE-accredited Advanced NSCLC Twitter Chat to allow you the opportunity to engage with the multidisciplinary faculty team that developed ASCP’s new Advanced NSCLC Tumor Board Simulation and discuss challenges you face related to the diagnosis, testing, and management of patients with advanced NSCLC.

The chat was moderated by:

Mohamed Abazeed, MD, PhD
@theabzlab

Associate Professor, Department of Radiation Oncology
Director, Center for Precision Radiotherapy
Scientific Director, Lung Cancer Program
The Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital

Amir Behdad, MD, MBA, FASCP
@AmirBehdadMD

Associate Professor of Pathology (Hematopathology), Medicine (Hematology and Oncology), and Pathology (Molecular Pathology)
Feinberg School of Medicine, Northwestern Medicine

Jyoti D. Patel, MD
@JPatelMD

Associate Vice Chair for Clinical Research, Department of Medicine
Professor of Medicine (Hematology and Oncology)
Robert H. Lurie Comprehensive Cancer Center, Northwestern Medicine

View or Claim Credit

When: Thursday, March 25, 8:00 p.m. EST

The Twitter Chat used the hashtag #NSCLCCHAT.

If you participated in the Twitter Chat, you can claim credit through the ASCP Online Store.

Claim Credit Here

Only participants in the live Twitter Chat can claim credit, but a record of the event can be viewed without credit at https://twitter.com/ASCP_Chicago.

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.